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ABSTRACT 
An improved chemically defined basal medium (CMRL-1415) has been used to advantage 
in studying the effects on trypsinized, newly explanted mouse embryo cells of certain glyco- 
proteins from plasma and serum, certain nonprotein macromolecules, and various com- 
binations of these,  in  stationary cultures.  When  protein  and  nonprotein fractions were 
separated from fetal calf serum, the entire growth activity was found to be associated  with 
the  protein. When  100  mg  %  of dialyzed, freeze-dried,  supernatant solution of Cohn's 
fraction V  (method 6)  from human plasma was used as a  supplement for CMRL-1415, 
there was considerable improvement in the cultures; and seromucoid prepared from calf 
serum had a similar effect.  Supernatant V was further fractionated by gel filtration to give 
a  threefold concentration of growth activity in a  single,  highly purified o~x-acid glycopro- 
tein (orosomucoid). Starch gel electrophoresis of horse serum that was used to supplement 
the basal medium revealed a decrease of both oq-acid  glycoprotein and ~-macroglobulin 
during the cultivation of mouse embryo cells. When horse serum was fractionated on DEAE- 
cellulose columns, the only fraction  that  showed  growth activity was a  slow as-globulin. 
When the ~2-macroglobulin of Schultze was prepared from horse  serum by salt precipita- 
tion, it was equally effective.  When the ~2-macroglobulin from horse  serum was tested  (at 
100  mg  %)  in combination with  otl-acid  glycoprotein from  Supernatant V,  seromucoid 
from calf serum,  or  unfractionated Supernatant V,  the  growth  response was greatly in 
excess of that produced by any of these supplements tested separately. The ~2-macroglobu- 
fin from horse serum could be replaced by certain nonprotein macromolecules (e.g.,  dex- 
tran or Ficoll). ~hus, dextran (mol.  wt.  100,000 to 200,000)  had no visible effect  on the 
cells when used alone at 0.1 or 1%. But when these levels of dextran were used in combina- 
tion with low molecular weight glycoproteins (e.g.,  unfractionated Supernatant V  at  100 
mg %), the cultures remained active and healthy for unusually long periods. 
Although one of our earlier media, CMRL-1066 
(22),  will  support  the  continuous multiplication 
of certain established cell lines, it will not support 
the continuous multiplication of newly explanted 
tissue  ceils  unless  supplemented  with  protein, 
which is usually added as whole serum. Over the 
past  several years,  investigators in many labora- 
tories have attributed growth-promoting or other 
desirable properties to  several fractions of blood 
serum and to various nonprotein macromolecules. 
In the present report, evidence is presented to in- 
dicate that certain high and low molecular weight 
glycoproteins  from  blood  serum,  when  added 
separately  to  chemically  defined  media,  confer 
considerable benefit upon newly explanted mouse 
embryo  cells  in  stationary  cultures,  as  do  also 
certain  nonprotein  macromolecules.  More  im- 
portant,  there  is  evidence that  certain combina- 
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glycoproteins and combinations of certain of these 
and nonprotein macromolecules, notably dextran, 
have a  marked  effect in promoting the long-con- 
tinued  multiplication  and  attachment  of  newly 
explanted  mouse  embryo  cells,  with  little  or  no 
cellular  degeneration.  An  improved  chemically 
defined  basal  medium,  CMRL-1415,  that  has 
been  especially  designed  for  use  with  these  and 
other supplements is described in the accompany- 
ing paper. 
MATERIALS  AND  METHODS 
The  procedures  followed  in  developing populations 
of  newly  explanted  cells  from  trypsinized,  whole 
mouse embryos, in preparing test cultures from tryp- 
sinized  cell  suspensions  in  plastic  flasks  fitted  with 
silicone stoppers,  and  in  preparing  the  cultures  for 
cell  counts  or  photography,  are  described  in  the 
accompanying paper. 
The  biochemical  procedures  used  in  preparing 
fractions of plasma and serum are described in sub- 
sequent  sections  of  the  report. 
Except  for  a  few  selected  experiments  in  which 
population-doubling  time  has  been  estimated,  the 
results  are  presented  photographically.  The  most 
convincing  results  were  often  obtained  in  experi- 
ments  in  which  cells  in  the  defined  basal  media 
serving as controls would begin to degenerate within 
a  few  days  whereas  replicate  cultures  containing 
useful supplements would remain healthy and active 
for  several  weeks.  This  situation  almost  always 
arose  in  experiments  in  which  the  cells  did  not 
seem as healthy as usual or when the inoculum size 
was  smaller  than  optimal.  Conversely,  when  the 
appearance  of the cells and the inoculum size were 
optimal,  cultures  sometimes  had  to  be  carried  for 
many  weeks  in  order  to  detect  appreciable  differ- 
ences between them.  Often,  under these conditions, 
the  effects  of  useful  modifications  in  the  medium 
were  revealed  more  clearly  by  improved  cellular 
morphology  and  mode  of  growth  than  by  appre- 
ciable  differences  in  population  density.  In  some 
instances,  experiments  had  to  be  discarded  after 
several weeks because cells in the control cultures in 
unsupplemented  defined  medium  CMRL-1415 
remained  so  healthy  and  vigorous  that  it  was  im- 
possible to  detect any real  advantage from the sup- 
plements being tested. 
EXPERIMENTS  AND  RESULTS 
Effect of Protein and Nonprotein 
Fractions of  Serum 
1.  SEPARATED  BY  SIMPLE  D~ALYSIS 
WITHOUT  RETAINING  THE  DIALYSATE:  In 
a  typical  experiment,  100  ml  of  pooled  fetal 
calf  serum  (Hyland  Laboratories,  Los  Angeles) 
were  placed  in  a  cellophane  dialysis  sac  (1 a/~-in. 
diam.; pore size, 48-A units) that was immersed in 
running tap  water for 48 hr and  then dialyzed  a 
further  24  hr  at  4°C  against  10  liters  of  0.12  u 
SAC1,  with  continuous  stirring  to  dissolve  the 
precipitated  globulins.  The  original  volume  in- 
creased to  128 ml and was concentrated to  100 ml 
by  pervaporation.  When  the  resulting  dialyzed 
serum was added to CMRL-1066 at a  level of 15% 
by volume and  tested on  newly  explanted  mouse 
cells, it showed growth activity equivalent to that 
obtained with the same level of undialyzed serum. 
2.  SEPARATED  BY  CONTINUOUS  ASEPTIC 
DIALYSIS  WITH  CONSERVATION  OF  THE 
DIALYSATE:  In  another  type  of experiment,  a 
continuous closed  dialysis  system  was  assembled 
from standard-taper Pyrex glassware.  The  system 
consisted of a  l-liter boiling flask  (with a  bottom 
outlet) fitted with Claisen connecting tubes and a 
Liebig  condenser.  The  condenser  was  connected 
to a  Soxhlet extractor provided with a  return tube 
to  the  bottom of the  boiling flask.  Four-hundred 
ml  of  ion-exchange  water  were  introduced  into 
the  boiling  flask  and  heat  was  applied  without 
vacuum and without cooling the condenser jacket. 
After  the  system  had  been  thoroughly  steamed 
out,  heat  was  reduced,  a  sterile  dialysis  sac  con- 
taining  75  ml  of fetal  calf serum  was  introduced 
into the extractor,  vacuum was applied,  and cold 
water  was  passed  through  the  condenser  jacket. 
The  distilled  water  was  cycled  continuously 
through the extractor  and over the serum sac for 
48 hr during which time the internal temperature 
did  not  exceed  56°C.  After  48  hr,  the  dialysate 
was concentrated by vacuum distillation to 75 ml. 
The dialyzed serum residue was dialyzed a  further 
24 hr against 5  liters of 0.12 M SAC1,  stirred con- 
tinuously  to  dissolve  precipitated  globulins,  and 
concentrated  to  75  ml  by  pervaporation.  The 
dialyzed  serum  residue  and  the  dialysate  were 
added to separate samples of CMRL-1066 at levels 
of 15 %  by volume and tested on newly explanted 
mouse  cells.  The  cell  growth  obtained  with  the 
dialysate  was  comparable  to  that  obtained  with 
CMRL-1066  alone,  whereas  the  dialyzed  serum 
residue  showed  considerable  growth  stimulation. 
3.  SEPARATED  BY  SALT  PRECIPITATION: 
Total serum protein and protein-free extracts from 
the  same  sample  of serum were  prepared  by  the 
method of Deutsch et el.  (8).  One-hundred nil of 
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Na2SO4 at 56°C, which precipitated all the pro- 
tein. The mixture was filtered by suction through 
a warm Buchner funnel into a filtration flask cooled 
in cracked  ice.  The filtrate,  which contained all 
the low molecular weight materials present in the 
original serum, was freed  of Na~SO4 by the addi- 
tion of a  calculated amount of CaC12. The pre- 
cipitated CaSO4 was filtered off  and the  filtrate 
was made isotonic by dilution with water. When 
this material was added to CMRL-1066 at a level 
of 15% by volume, it showed  no growth-promot- 
ing activity on newly explanted mouse cells.  But 
when the  protein residue was dissolved  in water 
and was dialyzed free of Na2SO4 by running tap 
water,  made  0.14  M with  respect  to  NaC1,  and 
reprecipitated according to the method of Michl 
(38)  with  (NH4)2SO4,  it  yielded  an  active  a- 
globulin fraction  that  stimulated  the  growth  of 
newly explanted mouse cells from the  same  sus- 
pension. 
4.  SEPARATED  BY  GEL  FILTRATION  WITH 
SEP~ADEX  O-25:  A  Sephadex  column  (45  X 
2.5  cm; Pharmacia, Uppsala, Sweden) was filled 
with a slurry of Sephadex G-25 gel that had been 
allowed to swell for a  few hours in ion-exchange 
water.  A  50-ml  sample  of fetal  calf  serum  was 
applied to the column and desalted according to 
the procedure of Flodin (17).  The serum proteins 
were recovered in the first portion of the effluent 
and all the low molecular weight constituents were 
recovered from 400 ml of the remaining effluent. 
Both fractions were concentrated by pervaporation 
to 50 ml, adjusted to 0.14 M NaC1, added to sepa- 
rate samples of CMRL-1066 at levels of 15% by 
volume,  and  tested  on  newly explanted  mouse 
cells. The growth activity was found to reside in 
the  protein  fraction,  not  in  the  low  molecular 
weight material. 
Effect of Low Molecular  Weight Glycoproteins 
from  Pooled  Human  Plasma  (Supernatant 
Fraction  V) 
In 1954, we tested  Cohn  (7)  fractions I  to V, 
inclusive, that  had  been  prepared  from  human 
serum (method 6)  by Dr.  A.  F.  Charles of these 
Laboratories.  When  these  fractions  were  tested 
singly or in combination, as  supplements for de- 
fined  medium  858  (21),  they  had  little  or  no 
growth-promoting activi  W for L-strain cells from 
mouse;  in fact,  fractions II  and  III  (which  in- 
cluded  the  gamma  globulins)  were  somewhat 
toxic.  Eagle  (10)  reported  similar findings with 
the same fractions prepared at the Harvard Medi- 
cal  School.  Because  these  observations led  us to 
question  the  wisdom  of  attempting  any  further 
purification of  Cohn's clinically useful fractions, 
we turned our attention to the seromucoids (51). 
These  low  molecular  weight  glycoproteins,  that 
are  not coagulable by heat  and are  not precipi- 
tated  by  sulfosalicylic  acid,  have  sedimentation 
constants of approximately 3S and are known to 
be  present  in  CMRL's  supernatant  solution  of 
Cohn's fraction V. These proteins represent about 
1 to 2 %  of the total serum protein and have the 
following electrophoretic composition (46):  50% 
albumin,  35%  al-,  11%  c~2-, 4%  [31- and  /33- 
globulins. 
Supernatant V, which is the solution remaining 
after  the  removal  of  fraction  V  (albumin)  by 
Cohn's  method  6  (7)  for  the  fractionation  of 
human plasma,  was  concentrated  about  15-fold 
in  vacuo,  dialyzed  24  hr  against  running tap 
water,  and  the  dialyzed  Supernatant V  concen- 
trate  was  dried  in vacuo from  the  frozen  state. 
The  product,  a  light  brown fluffy  powder,  was 
the  starting material for  the separation of glyco- 
proteins and had the following proximate analysis 
(by  weight):  albumin  40%  and  glycoproteins 
60%  (including  hexoses  15.5%,  hexosamines 
14.5%, sialic acid 9%, and fucose  1%, as prosthetic 
groups).  Twenty ml  of  a  4%  solution of dried 
Supernatant  V  in  0.005  M  sodium  phosphate 
buffer (pH 7.0) were applied to a chromatographic 
column (45  X  2.5 era) filled to a height of 40 cm 
with  a  suspension of  Sephadex  G-50  (medium) 
or G-75 (fine) in the same buffer. After the sample 
had  entered the  gel,  a  constant head  of  1 m  of 
0.005 ~  phosphate buffer  (saturated  with respect 
to chlorobutanol) was applied to the column from 
a  Mariotte bottle. The albumin appeared in the 
first portion of the effluent, as revealed by testing 
successive portions of it with 20% trichloroacetic 
acid.  After  passage  of  the  albumin, which  was 
discarded, the effluent was collected on an auto- 
matic fraction collector, the optical density of the 
fluid in each  tube  was  determined  in  a  Hilger 
spectrophotometer  (Hilger  &  Watts,  Ltd.,  Lon- 
don, England) at a  wave length of 280  m/z, and 
the contents of adjacent tubes showing UV absorp- 
tion were combined and lyophilized. In a typical 
experiment with  Sephadex  G-50,  a  sharply  re- 
solved  peak  (a)  and a  partially-resolved peak  (b) 
were  obtained. In this experiment, the following 
recoveries were obtained from the original 800 mg 
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albumin, 320  mg;  peak  a,  350  rag;  and,  peak  b, 
130  rag,  of  freeze-dried  materials.  When  these 
fractions  and  the  original  Supernatant  V  were 
subjected to  starch  gel electrophoresis  (49),  peak 
a was found to contain al-glycoprotein and peak b 
a  mixture  of  c~.~-glycoproteins  and  B-globulin. 
With Sephadex G-75,  three separate peaks of the 
same proteins were  obtained in the  same elution 
order.  The material from the first peak contained 
the  principal  glycoprotein  of  Supernatant  V 
(orosomucoid  or  al-acid  glycoprotein)  and  a 
small amount of an a2-glycoprotein. 
When 100 mg% of dialyzed, freeze-dried Super- 
natant  V  was used  as a  supplement for CMRL- 
1415 (to give CMRL-1415-SCVa), there was  con- 
siderable  improvement  in  the  appearance  of 
newly explanted mouse embryo cells (Figs.  1 and 
2).  When  the  Sephadex  subfractions  of  Super- 
natant V  had been prepared and tested (Fig. 3), it 
was found that  all the growth-promoting activity 
of Supernatant V  was contained in the  material 
eluted first from G-50 and G-75 columns (i.e., in 
G-50-a  and  G-75-a).  When  either  of  these  two 
subfractions  of  Supernatant  V  was  tested  at  35 
mg% in combination with  the  a2-macroglobulin 
of Schultze et al.  (48)  at  100  rag%  (Figs. 5  and 
6),  they  showed  a  far  greater  growth  response 
than  when  tested  alone.  When  unfractionated 
Supernatant  V  was  tested  in  combination with 
the ce2-macroglobulin (Fig. 7), the growth response 
was as striking as that obtained by combining the 
Sephadex subfractions with the a2-macroglobulin. 
By  treatment  with  neuraminidase  from  Vibrio 
1 Registered trademark. 
cholerae,  bound  sialic  acid  was  removed  from 
Supernatant  V  without  loss  of  growth  activity. 
Further  hydrolysis  with  mild  mineral  acid  or 
trypsin resulted  in progressive loss  of growth  ac- 
tivity. 
Effect of a2-Macroglobulin from Horse  Serum 
The  importance  of  the  c~2-macroglobulin  (48, 
47)  portion of normal serum supplements was in- 
dicated  by two  types of experiments: (A)  During 
column chromatographic  studies of normal horse 
serum,  a  series  of fractions were  separated  on  a 
diethylamino  ethylcellulose  (DEAE)  column  by 
the method of Robinson et al.  (44). These authors 
obtained  6  major  peaks  (I  to  VI)  from  human 
serum, but with horse serum the first peak was re- 
solved  into  two  (at  280  m#),  the  first  at  about 
500 ml of effluent followed by an inflection point 
and a  second higher maximum at about  750 ml. 
Because  of  this  difference,  the  major  peak  I  of 
Robinson et  al.  was  treated  by  us  as  two  inde- 
pendent peaks and were designated peaks Ia and 
Ib.  Adjacent  tubes  of effluent  corresponding  to 
each  peak  were  combined,  dialyzed,  and  freeze- 
dried  to  give  7  fractions.  When  these  fractions 
were  tested  as  supplements  for  CMRL-1415  in 
the  proportions  in  which  they  occur  in  whole 
horse  serum,  only fraction  Ib  showed  activity in 
promoting the  growth  of newly explanted  mouse 
embryo cells. When this fraction was subjected to 
starch gel electrophoresis,  it proved  to  be mainly 
a  slow  ~2-globulin together  with  a  trace  of  5'- 
globulin, which was eluted in fraction Ia. 
(B)  A  comparison  of the  protein  patterns  ob- 
tained by starch gel electrophoresis of normal horse 
serum and of the same serum that had been used 
FIGURE 1  Ten-day-old culture (342~6-1) of mouse embryo cells in medium CMRL-1415; 
MsE 194:T3(6).  (Embryos from mouse No. 194; culture is one of a series prepared after 
3rd trypsinization of cells, 6 days after tissues were explanted from embryos). X  120. 
FIGURE 2  Ten-day-old culture (34~26-17) in medium 1326-5 (CMRL-1415  supplemented 
with 100 mg %  Cohn's dialyzed, freeze-dried  Supernatant V from human plasma); MsE 
194:TS(6).  X  120. 
FmvaE 3  Thirty-five-day-old culture  (34172-7)  in medium  1828-6 (CMRL-1415  sup- 
plemented with 35 mg % Sephadex G-50-a fraction of Cohn's Supernatant V from human 
plasma); MsE 190:T4(9).  X  120. 
FIGURE 4  Twenty-eight-day-old  culture  (33873-4)  in  medium  1309-3 (CMRL-1415 
supplemented with  100 mg % ~-macroglobulin from horse  serum and 35 mg %  sero- 
mucoid from calf serum) ; MsE 171:T5(29).  >( 120. 
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FrO~RE 6  Eighteen-day-old culture  (3410%3)  in medium  131~-6  (CMRL-1415  supplemented with 100 
mg a/~ q2-macroglobulin from horse serum and 35 mg ~/~ Sephadex G-50-a fraction of Cohn's Supernatant 
V from human plasma); MsE 187:T4(9).  X  1~0. 
FmURE 7  Eighteen-day-old culture  (34107-7)  in medium  1335-1  (CMRL-1415  supplemented with 100 
mg %  a~-macroglobulin from horse serum and 100 mg %  Cohn's dialyzed, freeze-dried Supernatant V from 
human plasma); MsE 187:1"4(9).  X  120. as  a  supplement  for  the  cultivation  of newly  ex- 
planted  mouse cells revealed a  decreased intensity 
of the electrophoretic bands  corresponding  to the 
prealbumin  (orosomucoid  or  o~l-acid  glycopro- 
tein)  and  the o~2-macroglobulin of Schultze et  al. 
(48).  Consequently,  o~2-macroglobulin  (mol.  wt. 
about 850,000)  was isolated from horse serum on a 
preparative  scale  by  salt  precipitation  according 
to  the  method  of  SchSnenberger  et  al.  (47)  for 
human  serum.  The  product  was  electrophoreti- 
tally  homogeneous  (starch  gel)  and  had  growth- 
promoting  activity  similar  to  fraction  Ib  of  the 
DEAE  column  material.  But  this  activity  de- 
pended upon its integrity, which was destroyed by 
mild  acid  hydrolysis  or  gentle  tryptic  digestion. 
The response of newly explanted mouse embryo 
cells to the c~2-macroglobulin of Schuhze  in com- 
bination with various low molecular weight glyco- 
proteins is illustrated  in Figs.  4  to  7. 
Effect  of Seromueoid from Calf Serum 
The  seromucoids  (51)  include  several  water 
soluble,  low molecular  weight  glycoproteins  that 
are  not  coagulable  by  heat,  are  not  precipitated 
by sulfosalicylic acid,  and  migrate electrophoreti- 
cally with  the  al- and  o~2-globulin  fractions;  and 
a  few  of them  have  been  isolated  in  pure  form, 
notably  orosomucoid  or  o~l-acidic  seromucoid 
(53),  3.5S  o~-glycoprotein,  and  haptoglobin.  Be- 
cause  there  is  considerable  evidence  supporting 
the identical nature of orosomucoid and  Schmid's 
c~t-acid  glycoprotein  (45)  from  Cohn's  Super- 
natant  V,  2 we prepared  this seromucoid from calf 
serum  by  salt  precipitation  (55).  When  this  ma- 
terial  was  added  to  the  basal  medium  (CMRL- 
1415)  at  35  mg%,  its  effect on  the  growth  and 
survival  of  newly  explanted  mouse  embryo  cells 
was comparable  to that  of Supernatant  V.  When 
it was tested in combination with c~2-macroglobu- 
lin  (Fig.  4),  it has as pronounced  an effect as did 
Supernatant  V  with  this  same  macromolecular 
supplement  (Figs. 5 to 7). 
Orosomucoid  was  then  separated  from  the 
seromucoid  complex  of Supernatant  V  by  chro- 
matography  on  DEAE cellulose according  to  the 
procedure  of Kalous  and  Poncav~  (26).  Later,  a 
Pentex,  Inc.  (Kankakee,  Illinois),  distributes  sero- 
mueoid  fractions  that  are  almost  identical  with 
the  dialyzed,  freeze-dried  supernatant  solution  of 
Cohn's  fraction  V,  are  prepared  by  salt  precipita- 
tion  (55)  from the serum of various species,  and  are 
designated  glycoprotein  (Cohn  Fraction  VI). 
purer  preparation  (electrophoretically)  of  oroso- 
mucoid was obtained  by applying Supernatant  V 
to a DEAE cellulose column and then by applying 
the  eluate  to  a  carboxymethyl  cellulose  column 
(2). Attempts are now being made to evaluate the 
growth-promoting  activity of these  fractions. 
Supplementation  of Basal  Media  with  Non- 
protein  Maeromoleeules  in  Combination  with 
Low Molecular  Weight  Glyeoproteins 
When  it  was  found  that  the  o~2-macroglobulin 
from horse serum in combination with certain low 
molecular  weight  glycoproteins  (Figs.  6  and  7) 
had  a  much  greater  effect  on  newly  explanted 
mouse  cells  than  any  of  these  fractions  tested 
separately, we explored the possibility of substitut- 
ing  certain  high  molecular  weight  polymers  for 
the  macroglobulin.  Although  certain  polymers 
(e.g.,  dextran,  polyvinylpyrrolidone,  and  methyl 
cellulose) showed little or no effect when tested by 
us  10  yr  ago in  stationary  cultures  of established 
cell  lines  in  medium  CMRL-1066,  dextran  and 
Ficoll (Pharmacia,  Uppsala, Sweden) now showed 
very dramatic  effects on  newly  explanted  mouse 
cells when  tested  in  combination  with  the  glyco- 
proteins  prepared  in  the  present  study.  When 
Ficoll  (mol.  wt.  approx.  400,000)  was  added  to 
basal medium CMRL-1066  at levels of 5  to  10% 
(w/v), it produced many large and densely granu- 
lar round  cells with abnormally  small nuclei; and 
many  of  the  cells  contained  one  or  more  cyto- 
plasmic vacuoles. But when it was tested  at these 
same levels in combination with seromucoid from 
calf serum,  or  the  Sephadex  G-50(a)  fraction  of 
Supernatant  V, cell growth was greatly stimulated 
and more nearly normal in appearance  than with 
Ficoll alone,  although  there  were  still  many  ab- 
normally  large  cells  with  small  nuclei.  When 
Ficoll was reduced  to  2  to  5  per  cent and  tested 
in  combination  with  fractionated  and  unfrac- 
tionated Supernatant V, growth was more normal 
in  appearance  (Figs.  8  and  9). 
When  dextran  with  a  molecular  weight  of 
100,000  to  200,000  (Nutritional  Biochemicals 
Corp.,  Cleveland)  was  tested  in  basal  medium 
CMRL-1415  at  levels  of  0.1  to  2.0%,  the  cells 
were usually indistinguishable from those in basal 
medium alone (Figs.  12 and  13).  At 5% there was 
little  or  no  growth  stimulation,  but  there  were 
were many large vacuolated cells (Fig.  10),  as with 
Ficoll. At 7 %  the cell population  was more dense 
and more normal in appearance,  and the majority 
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whorls that often surrounded heavier centers of in- 
creased cellular proliferation (Fig.  11 ). A few large 
cells,  densely  granular  cells,  and  cells with  cyto- 
plasmic vacuoles were also seen. 
When  0.1  or  1%  dextran  in  CMRL-1415  (to 
give CMRL-1415-D 1) was tested on mouse embryo 
cells  in  combination  with  the  low  molecular 
weight seromucoid from calf serum, with dialyzed, 
freeze-dried preparations  of the supernatant  solu- 
tion  of  Cohn's  fraction  V  of human  plasma  (to 
give CMRL-1415-DSCVI), or with Sephadex sub- 
fractions of Supernatant  V, a pronounced stimula- 
tion of growth occurred that was greatly in excess 
of that obtained with the glycoproteins alone, and 
there  was  little  evidence  of  the  cellular  abnor- 
malities seen with Ficoll. Dextran with a molecular 
weight of 100,000  to 200,000 in combination with 
the low molecular weight glycoproteins just  men- 
tioned  (Figs.  14  to  16)  yielded  healthy,  active 
cultures  that  remained  completely free  of visible 
degeneration for long periods.  In a  typical experi- 
ment in which mouse embryo cells were cultivated 
in  CMRL-1415-DSCV  containing  1%  dextran 
(the  recommended  level)  and  100  mg%  Super- 
natant  V,  the  approximate  population-doubling 
time  was  21/~ days,  whereas  in  replicate  cultures 
prepared  with  unsupplemented  CMRL-1415  it 
was 41/~ days. 
The usual  serum supplement for defined media 
is 5  to 20%  by volume, which  increases  substan- 
tially the total solids, specific gravity, and viscosity, 
and  contributes  a  colloid osmotic pressure  (COP) 
that is usually absent in defined media.  The addi- 
tion of 1% dextran  (mol.  wt.  100,000  to 200,000) 
to CMRL-1415 results in expected low increments 
in  total  solids  and  specific  gravity,  whereas  the 
COP and relative viscosity approach  the accepted 
values for human  plasma  (as an 8 %  protein  solu- 
tion)  as  follows:  COP,  19.3  mm  Hg  (plasma  = 
20 to 28 mm Hg); viscosity,  1.6  (plasma  =  1.7  to 
2.0). 
The  normal  appearance  of mouse embryo cells 
in  CMRL-1415  supplemented  with  0.1  to  2% 
(w/v)  dextran  (Fig.  13),  the  abnormally  large 
cells in 5 % dextran (Fig. 10),  and their unexpected 
return  to near normal  appearance  in  7 %  dextran 
(Fig.  11),  is related  to the peculiar osmotic prop- 
erties  of these  solutions.  We  have  measured  the 
colligative properties  of 1 to  10%  (w/v)  aqueous 
dextran  solutions  and  have  found  that  the  COP 
increases  exponentially  as  a  function  of  concen- 
tration  with  a  sharp  discontinuity  at  a  critical 
concentration  of  5%.  At  this  concentration,  the 
COP  is  50%  less  than  the  COP  of  1%  dextran. 
This  unusual  behavior  results  in  the  passage  of 
water  in the direction opposite to that anticipated 
from ordinary  osmotic considerations so that  cells 
in  CMRL-1415  supplemented  with  5%  dextran 
become greatly enlarged. 
DISCUSSION 
Part  of  the  early  difficulty  experienced  by  our- 
selves and  others  in  attempting  to  assess  the  nu- 
tritive  value  of  serum  fractions  was  due  almost 
certainly to the use of established  cell lines in the 
test  cultures.  Although  our  first  defined  media 
(40)  were  developed  for  freshly  explanted  chick 
embryo  cells,  we  eventually  turned  to  Earle's  L 
strain cells from mouse as an easy means of making 
replicate  cultures  and  assessing  the  results  quan- 
titatively. Eventually, however, it became evident 
that  this  and  other  established  cell lines  become 
adapted, very easily, to the more elaborate defined 
media and lack the sensitivity that  is so necessary 
in  testing minor changes  made in the medium  as 
well  as  materials  added  as  supplements.  For  the 
work  reported  here  we  chose  newly  explanted 
FIGURE8  Twenty-four-day-old  culture  (34~11-1)  in  medium  CMRI~1415;  MsE 
193:T8(6).  X  1~0. 
FIGURE 9  Twenty-four-day-old culture  (84~11-5)  in medium 1363-1  (CMRL-1415 sup- 
plemented with ~% Fieoll and 1~0 rag% Cohn's dialyzed, freeze-dried Supernatant V from 
humau plasma); MsE 193:T3(6).  X  1~0. 
FIGURE 10  Twenty-one-day-old culture  (84~17-8) in medium 1875-1 (CMRL-1415 sup- 
plemented with 5% dextran, mol. wt. 100,660 to ~00,600); MsE 198:T4(9).  X  120. 
FIGURE 11  Twenty-one-day-old culture (34~17-5) in medium 1368-1 (CMRL-1415 sup- 
plemented with 7% dextran, mol. wt. 1{~0,060 to ~00,000);  MsE 193:T4(9).  )<  1~0. 
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FIGL~rtE 13  Forty-two-day-old  culture  (34338-3)  in  medium  1386-4 (CMRL-1415  supplemented with 
1% dextran, mol. wt. 100,000 to ~00,000);  MsE e0~:T3(7).  X  1~0. 
I~Gr3RE 14  Forty-two-day-old culture  (84338-5)  in  medium  1393-6 (CMRL-1415  supplemented with 
1% dextran, moh wt.  100,000 to  ftO0,O00,  and  100 mg %  Cohn's  dialyzed,  freeze-dried Supernatant  V 
from human plasma); MsE ~0e:T3(7).  X  1~0. 
548 FIGURE 15  Fifteen-day-old  culture  (34~67-6)  in  medium  1394-1 (CMRL-1415  supplemented  with 
0.1% dextran, tool. wt.  100,000 to ~00,000, and 100 nag %  Cohn's dialyzed, freeze-dried Supernatant  V 
from human plasma); MsE 197:T3(6).  X  1~0. 
FIGURE 16  Fifteen-day-old  culture  (34~67-10)  in  medium  1:398-~  (CMRL-1415  supplemented  with 
1.0% dextran, mol. wt.  100,000 to  ~00,000,  and  100  mg %  Cohn's  dialyzed, freeze-dried Supernatant 
V from human plasma); MsE 197:T3(6).  X  1~0. 
549 mouse  embryo  cells that  had  been  subcuhured  a 
sufficient number  of times  (2  to 3  times in 6  to 9 
days)  to  render  them  a  bit  more  homogeneous 
than freshly explanted cells, but not often enough 
for  them  to  lose  their  initial  sensitivity  to  life 
outside the organism. 
Fischer  and  his  associates  (13)  worked  exten- 
sively with  dialyzed  serum  and  stressed  the  im- 
portance  of low molecular weight growth factors. 
Later,  Harris  (20)  concluded  that  the  defined 
media  then  existing  were  all  deficient  in  one  or 
more factors that occur in serum dialysate and are 
essential  for  growth;  and,  Eagle  (11)  found  that 
serum does, in fact, contain one or more low molec- 
ular weight growth factors,  either bound  to serum 
protein or formed from it on proteolysis.  In  1951, 
Jacquez and Barry  (25),  working with rat cells in 
washed plasma clots, found that the entire growth- 
promoting activity of exhaustively dialyzed human 
placental cord serum was associated with the non- 
dialyzable  fraction.  More  recently,  Lockart  and 
Eagle  (35)  found  dialyzed  serum  as  effective  as 
whole  serum  for  heavily  seeded  cultures  but  not 
for cloning experiments with the same cell strains. 
Metzgar  and  Moskowitz  (37)  cultivated  various 
cell lines in proteln-free dialysates of horse serum; 
and  Gwatkin  (19)  reported  that  CMRL-1066 
supplemented  with a  dialysate of horse  serum in- 
creased the plating efficiency of L cells to a  degree 
comparable  with  that  obtained  when  the  supple- 
ment  consisted  of whole  serum.  It  is  likely that 
these dialysates  contained  substantial  amounts  of 
protein  that  remained  undetected  by  the  sulfo- 
salicylic  acid  and  biuret  protein  tests  that  were 
used.  In  any  event,  it  has  been  our  experience 
that  simple  dialysis  uncomplicated  by  the  addi- 
tion  of  proteolytic  enzymes  does  not  reduce  the 
growth-promoting activity of dialyzed serum when 
used as a  supplement for CMRL-1066 or CMRL- 
1415,  under  the  condition  of the  present  experi- 
ments.  It should  be remembered  that  the  degree 
of complexity  of  a  basal  medium  to  which  test 
supplements  are added  determines the response of 
the  cells  to  these  supplements,  i.e.,  a  relatively 
simple basal medium such as  199  or Eagle's mini- 
mal essential medium makes greater demands on a 
protein  supplement  than  a  more completely ade- 
quate  medium  such  as  CMRL-1066  or  CMRL- 
1415. 
In  1923,  Carrel  and  Ebeling  (5)  obtained  a 
growth-promoting  factor  for  chicken  fibroblasts 
by  supplementing  Tyrode's  solution  with  globu- 
lins  that  had  been  precipitated  from  adult  fowl 
serum  with  CO2.  But  despite  renewed  interest  in 
the last decade, knowledge of the growth-promot- 
ing  properties  of  serum  proteins  is  still  meager. 
Quite  recently,  the  importance  of low molecular 
weight  globulins  was  demonstrated  by  reports 
from other laboratories of a  serum factor that  was 
said  to  promote  flattening  and  adherence  of cer- 
tain  strain  cells to  glass.  Fetuin  (42,  9)  is  an  ~xl- 
glycoprotein  (mol.  wt.  48,400)  that  accounts  for 
about  45 %  of  the  proteins  of  fetal  calf  serum. 
Lieberman  and  Ove  (33,  34)  obtained  a  glyco- 
protein  from  bovine serum  that  was  said  to  pro- 
mote the attachment  of human  appendix  cells to 
glass.  Fisher et al.  (15)  concluded  that fetuin had 
this  same  effect  on  HeLa  cells.  Later,  the  same 
authors  (16)  reported  the  quantitative  growth  of 
single  HeLa  cells on  glass  in  a  defined  medium 
supplemented with serum albumin and fetuin, but 
Lieberman  et  al.  (32)  made  further  purification 
studies  and  decided  that  purified  fetuin  lacks 
biological  activity.  A  year  later,  Spiro  (50)  also 
reported  a  highly  purified  fetuin  from  fetal  calf 
serum  that  was  inactive,  although  it  is  possible 
that  in both instances the activity may have been 
destroyed  by  the  purification  procedures  (14). 
More recently, Marr et al.  (36)  used the prepara- 
tive ultracentrifuge to separate fractions from fetal 
calf  serum  and  found  growth  activity  in  fetuin 
and  another glycoprotein, c~-macroglobulin. They 
attributed  the growth  activity to common chemi- 
cal  groupings  found  in  both  glycoproteins,  to  a 
common  trace  protein,  or  to  a  low  molecular 
weight material  bound  by both  proteins.  Earlier, 
L. Weiss (54)  studied the adhesion of human cells 
to  glass  and  found  that  cells  that  had  lost  their 
adhesive  properties  after  trypsin  treatment  could 
regain them if whole serum or serum fraction G2 
of Kekwick  and  Mackay  (29)  was  added  to  the 
medium.  Fraction  G2,  which  contains  macro- 
globulin and other c~-globulins (4, 43), was said to 
be interchangeable with whole serum for adhesion 
of  cells  to  glass  but  not  for  nutrition.  In  1951, 
Jacquez  and  Barry  (25)  prepared  albumin  and 
globulin  fractions  from  human  placental  cord 
serum  by  ammonium  sulfate  precipitation  and 
found all the growth activity of the original serum 
was  present  in  the  globulin  fraction.  When  sub- 
fractions were prepared from the globulin fraction, 
some  activity  was  found  in  all  of  them.  Later, 
Katsuta  et al.  (27)  found  that  growth  activity for 
Yoshida  ascites  tumor  cells  of the  rat  was  asso- 
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as obtained by zone electrophoresis,  cold ethanol, 
or  ammonium  sulfate  precipitation  of  dialyzed 
horse serum. 
A growth-active globulin has also been isolated 
by Michl (38, 39) by ammonium sulfate precipita- 
tion.  The  addition of this  globulin to  a  defined 
medium  containing  serum  albumin  or  methyl 
cellulose  supported  maximal  growth  of  freshly 
explanted rabbit heart and kidney cells and various 
established cell lines.  Tozer and Pirt (52)  studied 
the  macromolecular  growth-promoting  fractions 
of dialyzed calf serum separated by electrophoresis 
on a cellulose powder column, by continuous-flow 
paper curtain electrophoresis,  and by gel filtration 
on  Sephadex  G-200  columns.  Because  these  in- 
vestigators felt  the  "attachment  factor"  may  be 
separate  from  that  for  growth,  they  tested  their 
fraction  on  suspension-type  cultures  of  L-  and 
ERK-strain cells in a defined medium containing 
bovine  serum  albumin,  insulin,  thyroxine,  and 
catalase,  and  concluded  that  the  activity  of 
dialyzed serum was associated  with albumin and 
with an a-macroglobulin. Holmes and Wolfe (23, 
24)  separated  two  components  (1  and  2)  from 
dialyzed bovine serum by curtain electrophoresis. 
Both components stimulated the growth of certain 
human cell lines but only component 1 promoted 
cellular attachment and  spreading.  The  growth- 
stimulating material  was  associated  with  the  c~- 
globulins during electrophoresis. 
In  our  experience,  attachment  and  spreading 
of cells has been possible in all protein-free media 
reported  from  this  laboratory  since  1950, often 
without prolonged growth and multiplication. It 
doesn't seem realistic at present, therefore,  to at- 
tribute  these  various  qualities  to  separate  and 
distinct factors  (or serum fractions). In any event, 
it has been known in tissue culture laboratories for 
many years that attachment and spreading of cells 
can be Mocked  indefinitely, even in the presence 
of fetal  calf serum,  by  placing them  in  culture 
vessels with unsuitable surfaces. 
There is general agreement on the decrease  of 
ce2-globulins in serum supplements used in the cul- 
tivation of cells  and tissues,  as  revealed by elec- 
trophoresis  (30,  31,  18). In  this  laboratory,  we 
have confirmed the disappearance of ce2-globulins 
from the medium and have established that it is 
the a2-macroglobulin  that decreases in horse serum 
used to supplement CMRL-1066 during the culti- 
vation of  newly explanted  mouse  embryo  cells. 
Because  ~x2-macroglobulin has the  same mobility 
as  other  ~2-globulins during paper  and  moving 
boundary electrophoresis,  the  specific  disappear- 
ance of c~2-macroglobulin was not apparent until 
it  was  revealed  by  starch  gel  electrophoresis. 
Similarly,  c~l-acid  glycoprotein  (orosomucoid), 
which has  a  distinct and separate  mobility from 
other c~l-globulins during starch gel electrophore- 
sis, was also taken up by the cells,  but to a lesser 
extent. 
Over  the  years,  the  most  adequate  media for 
animal cells in vitro have consisted of plasma or 
serum and tissue extracts, in suitable diluents. By 
analogy,  the  ideal  chemically  defined  medium 
should contain the essential nutrients and possess 
the physicochemical properties of a  transudate of 
blood plasma such as  lymph or interstitial fluid. 
Some  investigators  (I,  52)  have  supplemented 
defined  media  with  well  characterized  proteins 
such as insulin and catalase, but the amounts used 
were quantitatively  insignificant. Others (12, 6, 28, 
3, 41) have tested  methyl cellulose,  dextran, poly- 
vinylpyrrolidone (PVP),  Ficoll,  serum albumin, 
ovalbumin, acacia,  and  alginic acid,  as  supple- 
ments for  various types of media,  some  of them 
defined.  Thus,  Katsuta  et  al.  (28)  used  alginic 
acid,  dextran, and PVP  in 7-day stationary cul- 
tures of rat  ascitic  tumor cells  and found alginic 
acid and dextran (mol.  wt.  50,900)  to be greatly 
inferior to  0.1%  PVP  (mol.  wt.  70,000),  which 
they reported could replace 99.5 % of the dialyzed 
serum protein present in a  control medium that 
included 20%  dialyzed  bovine serum and  0.4% 
lactalbumin hydrolysate in saline.  More recently, 
Moskowitz  and  Schenck  (41)  reported  that  the 
addition of human serum albumin to CMRL-1066 
protected  cells  of various  established  lines from 
growth-inhibiting factors  that  were  separated  by 
dialysis,  along  with  growth-promoting  factors, 
from an extract of porcine pancreas; and Brinster 
(3)  studied  the  ability  of  certain  nonprotein 
polymers to  replace  the  physical properties  of a 
bovine serum albumin supplement (0.1%) during 
the  development  of  mouse  ova  in  a  defined 
medium. He found that various methyl cellulose 
preparations were ineffective substitutes for  albu- 
min  whereas  PVP  (mol.  wt.  150,000),  acacia, 
dextran,  and  Ficoll responded favorably. 
In  general,  recent  work  in  this  and  other 
laboratories indicates that  two  separate  o~-globu- 
fins in serum are at least partly responsible for its 
growth-promoting effects.  They  are  both  glyco- 
G.  M.  HEALY AND R.  C.  PARKER  Defined  Tissue Culture Media Supplements  551 proteins  and  are  further  characterized  by  their 
molecular  weights.  The  low molecular  weight  a- 
globulin (mol. wt. 40,000 to 50,000)  occurs in sero- 
mucoid  and  in  Cohn's  supernatant  solution  V 
(method  6).  The  high molecular weight a-globu- 
lin  (tool.  wt.  about  850,000)  is  the  a2-macro- 
globulin that was first isolated from human  serum 
by Schultze et al.  (48).  We have found that  these 
c~-globulins are  synergistic  and  can  substitute  for 
whole  serum,  at  least for a  time,  if they are  used 
as  supplements  for  suitably  designed  chemically 
defined  media.  And  while  the  low  molecular 
weight  a-globulin  seems  to  be  essential,  the  a~- 
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